Comparison of detection of significant and insignificant carcinoma using systematic and targeted MRI/TRUS fusion prostate biopsy

Abstract

Detection of insignificant prostate cancer by systematic biopsy is significantly higher than by targeted MRI fusion biopsy. MRI/TRUS targeted biopsy in combination with systematic biopsy had a significantly higher detection rates than systematic biopsy in the repeated biopsy only.

Keywords

• Prostate cancer
• diagnostics
• MRI
• prostate biopsy
• fusion